On the campaign trail, President-elect Trump ran on his record of expanding consumer and patient choice. He even went out of his way during his debate with President Biden to tout a 2018 law he signed giving terminally ill patients a “Right to Try,” promising medications unapproved by the Food and Drug Administration (FDA). However, it remains unclear whether the President-elect will push the notoriously risk-averse FDA to get its act together.
Read Full Article »